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z.2013.05Abstract Background: Asthma is a multifactorial inﬂammatory disorder that might result from
the interaction of multiple genes and environmental factors. Several studies of genetic epidemiology
have reported the association of cytokine genes with asthma among various populations. However,
the results are inconsistent and inconclusive.
Objective: To determine the association of cytokine gene polymorphisms with asthma suscepti-
bility in adult Egyptian cases.
Subjects: The study included, 50 adult Egyptian asthmatic cases with a mean age of
53.62 ± 14.61 years in addition to 98 healthy individuals as control. For all participants, DNA
was isolated from peripheral blood samples and analyzed for TNF-a-308 G > A, IL-10-1082
G > A, IL-6-174 G > C and IL-1Ra VNTR polymorphisms.
Results: The comparison between the cases and controls has showed signiﬁcantly higher fre-
quency of the genotypic polymorphisms: IL-10-1082 AG+GG (dominant mode) (76.1% vs.
91.8%, p= 0.01, OR = 0.3, 95% CI (0.1–0.7), TNF-a-308 GA+ AA (dominant mode) (72.0%
vs. 93.9%, p= 0.001, OR= 0.17, 95% CI = 0.06–0.47) and IL-1RA VNTR heterozygous geno-
type A1A2 (90.0% vs. 58.8%, p= 0.0003). Otherwise, compared to controls, cases showedctor; IL, interleukin; IL-1Ra,
le nucleotide polymorphism;
; PCR–SSP, polymerase chain
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(dominant mode) (92.0% vs. 94.9%, p= 0.5, OR = 0.6).
Conclusions: The IL-10, TNF-a and IL-1Ra allelic variants showed a potent association with
chronic asthma among Egyptian cases that might be used as markers with a potential impact on
prophylactic and or therapeutic measures for asthma control. Whereas the IL-6-174 allelic variants
showed no association with chronic asthma among Egyptian cases.
ª 2013 Production and hosting by Elsevier B.V. on behalf of The Egyptian German Society for Zoology.Introduction
Asthma is one of the most common chronic airway inﬂamma-
tory diseases characterized by reversible airway obstruction
and by bronchial hyper-responsiveness (BHR) with periodic
episodes of wheezing. Asthma and atopy have a complex back-
ground that may result from the interaction of genetic and envi-
ronmental factors (Custovic et al., 2012). The control of asthma
and response to medication is different in patients, and different
asthmatics show various levels of asthma severity and progress
depending on multiple factors especially genetic proﬁle of the
patients. The airway inﬂammatory response of asthma is now
known to be associated with the release of a number of inﬂam-
matory mediators and cytokines. The genes that predispose
individuals to asthma are not consistent among populations
as one individual may have a cytokine expression pattern totally
different from another (Michel et al., 2010). In fact, clinical
symptoms of asthma may reﬂect an imbalance in pro- and
anti-inﬂammatory cytokine levels (Choi et al., 2008). However,
cytokines play a pivotal role in the regulation of immune re-
sponse and the polymorphic structure of the regulatory regions
in the promoters of cytokine genes could affect the serum levels
of cytokines, consequently may confer ﬂexibility on the immune
response (Melk et al., 2003; Stanilova andMiteva, 2005).There-
fore, a large number of studies have focused on the association
between cytokine gene polymorphisms and asthma risk (Steinke
et al., 2008; Himes et al., 2009).
Interleukin-10 is one of pleiotropic immunoregulatory cyto-
kines formed by alveolar macrophages, T-regulatory cells, B
cells, mast cells, monocytes, and pulmonary dendritic cells
(Miteva and Stanilova, 2008). Alveolar macrophages in asth-
matic patients were found to produce signiﬁcantly less amount
of IL-10 (Zhang et al., 2002). The gene for IL-10 is located on
chromosome 1q31–32, a genomic region linked to asthma and
related phenotypes (Yu et al., 2004). A number of polymor-
phisms in the promoter region of IL-10 gene have been de-
scribed; in particular, the SNP at position 1082A/G of
noting that IL-10A allele was reported to be associated with
lower production of IL-10 (Moore, 2001). Several studies
examined the association of IL-10 polymorphisms with
allergic diseases. However, the results have been inconsistent
(Karjalainen et al., 2003; Chatterjee et al., 2005; Sohn et al.,
2007; Kim et al., 2009).
IL-6 is another immunoregulatory pleiotropic cytokine that
plays a role in inﬂammation of asthma (Co´rdoba-Lanu´s, 2008;
Rincon and Irvin, 2012) and increased levels of IL-6 in serum
have been found in asthmatic patients (Yokoyama et al.,
1995). More importantly, a study examining IL-6 in the broc-
hoalveolar lavage ﬂuid (BALF) has shown increased levels of
IL-6 in active asthmatic patients compared with the levels in
healthy nonsmoker subjects, stable asthmatic and non-asth-
matic patients receiving mechanical ventilation (Tillie-Leblondet al., 1999). In addition, increased levels of IL-6 in the BALF
from patients with ‘‘intrinsic’’ asthma compared with the levels
in patients with allergic asthma have also been reported Vir-
chow et al., 1996), suggesting that IL-6 may play a role beyond
patients with allergic asthma which only accounts for about
50% of all asthmatics. The gene encoding IL-6 was mapped
to chromosome 7p21 (Yalc¸ın et al., 2011). A number of poly-
morphisms in the IL-6 gene promoter region exhibited to be
related to cytokine plasmatic levels. Most of the studies con-
ﬁrmed that IL-6-174 G/C was associated with different inﬂam-
matory diseases (Fishman et al., 1998). However, the GG and
GC genotypes led to a high production of IL 6, while, CC
genotype led to a low production of this cytokine (Morse
et al., 1999). Consequently, this variant is associated with re-
duced pulmonary capacities (Daneshmandi et al., 2012).
Tumor necrosis factor-a (TNF-a) is a potent proinﬂamma-
tory cytokine that participates in the airway inﬂammatory re-
sponse in cases with atopic asthma. However, pervious study
reported that the TNF-a plays a key role in the pathogenesis
of bronchial asthma (BA) among various populations and in-
creased bronchial hyper responsiveness (Gao et al., 2006;
Daneshmandi et al., 2012). TNF-a gene is located in the hu-
man major histocompatibility complex (MHC) on chromo-
some 6p21.3 and its expression is increased in cases of severe
asthma (Ying et al., 1991). This site was previously linked with
asthma susceptibility and genetic studies have identiﬁed associ-
ations between TNF-a gene polymorphisms. Indeed, TNF-a-
308 promoter polymorphism is biallelic, G and A noting that
the A allele was reported to be associated with increased levels
of TNF-a in the plasma and bronchoalveolar lavage ﬂuid from
asthmatic airways (Choi, 2005). Also, it was reported to be
associated with increased in vitro transcription of TNF-a
and TNF-a level in the stimulated human white blood cells
(Lee et al., 2009). Recent meta-analysis indicated that the
TNF-a-308 G/A polymorphism is associated with an increased
risk of asthma in adults and children, in Asians but not in Cau-
casians, and in atopic population but not in non-atopic popu-
lation (Zhang et al., 2011).
IL-1Ra has anti-inﬂammatory activity and thereby reduces
airway responsiveness due to the initially secreted proinﬂam-
matory cytokines (Mao et al., 2000). The IL-1 cluster, mapped
on chromosome 2q12–14, harbors the IL-1Ra gene that con-
tains an 86 bp VNTR polymorphism in intron 2 (Tarlow
et al., 1993; Hakonarson and Wjst, 2001) resulting into ﬁve dif-
ferent alleles with numbers of repeats ranging between 2 and 6.
The two most common alleles, allele 1 and 2, account for
approximately 98% of all observed alleles. In vitro and
in vivo studies investigating the level of IL-1Ra have found
IL-1Ra alleles to inﬂuence the levels of the expressed protein
(Ahirwar et al., 2008).
In this study, we investigated the associations of the
TNF-a-308G/A, IL-6-174G/C, IL-10 1082G/A and IL-Ra
Figure 1 Ampliﬁcation products. Lane 1: size marker VIII.
Lanes 2 and 3: ampliﬁed product of IL1 Ra (VNTR) with 2 alleles
of size 404, 242 bp (lane 2) and one allele of size 404 bp (lane 3).
Lane 4: ampliﬁed product of IL-6 shows a band size of 234 bp.
Lanes 5 and 6: ampliﬁed product of TNF-a band size 836 bp.
Lanes 7 and 8: ampliﬁed product of IL-10 band size 179 bp.
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Subjects and methods
Participants composed of 50 adult chronic asthmatic cases
who were followed up in the Clinics of College of Medicine,
Mansoura University. They included 22 (44%) males and 28
(56%) females with an age mean of 53.62 ± 14.61 years. Of
these cases, 15 (30%) had a positive parental consanguinity
and 24 (48%) had a positive family history of asthma. Asthma
diagnosis was based on the international consensus reports on
diagnosis and treatment of asthma and physicians’ recommen-
dations (National Heart, Lung and Blood Institute, 2007).
Polymorphisms of cytokine genes of cases were compared with
those of 98 healthy unrelated volunteers from the same local-
ity. They included 52 males and 46 females with a mean age
of 44.9 ± 6.7 years.
It is worth mentioning that all the volunteers and the cases
have already agreed to use their samples in genetic
examination.
DNA isolation and PCR
Genomic DNA was extracted from fresh peripheral blood
(3 ml in EDTA) using a commercially available kit (Qiagen,
Germany) according to the manufacturer’s instruction and
then stored at 20 C till use. Single nucleotide polymor-
phisms (SNPs) related to the TNF-a (-308), IL-6 (-174) and
IL-10 (-1082) were determined using PCR with sequence-spe-
ciﬁc primers (PCR–SSP) in two reactions employing one com-
mon forward and two reverse primers; while IL-1Ra VNTR
polymorphism was determined by a single PCR reaction
employing one forward and one reverse primer. The reaction
mix was done in 25 l1 volumes of: 100 ng of template DNA
added to a mix of 1 lM of each common/speciﬁc primer,
1 mM MgCl2, 200 lM of each dNTP, and 1 U of Ampli Taq
polymerase (Applied Biosystems, USA). In each PCR run, a
heterozygous control template was used to ensure accuracy.
The sequences of designed primers and PCR conditions for
each gene are shown in Table 1. The resultant PCR products
were resolved by electrophoresis on 2% agarose gel stained
with ethidium bromide for 20 min at 200 V. The gel was then
photographed on UV light (320 nm) and scored for the pres-
ence or absence of an allele speciﬁc band (Fig. 1).Table 1 Primer sequences and PCR conditions of the different stu
Gene Primer sequences 5‘–3‘ PCR
IL-10 1082G/A F: AGC AAC ACT CCT CGT CGC AAC 179
R1: CCT ATC CCT ACT TCC CCC
R2: CCT ATC CCT ACT TCC CCT
IL-6-174G/C F: GAG CTT CTC TTT CGT TCC 234
R1: CCT AGT TGT GTC TTG CC
R2: CCC TAG TTG TGT CTT GCG
TNF-a-308G/A F: CTG CAT CCC CGT CTT TCT CC 836
R1: ATA GGT TTT GAG GGG CAT CG
R2: ATA GGT TTT GAG GGG CAT CA
IL-1Ra VNTR F: TCC TGG TCT GCA GGT AA 404–
R: CTC AGC AAC ACT CCT ATStatistical analysis
Data were processed and analyzed using the Statistical Pack-
age of Social Science (SPSS, version 17.0). The frequency of
studied allelic polymorphisms among cases was compared to
that of controls and tested for positive association using Fish-
er’s exact test and Odds ratio with a minimum level of signif-
icance of <0.05.
Results
Comparing the genotypic variants of cases to controls pertain-
ing their IL-10-1082 A > G polymorphism, it was noticed that
the frequency of GG+GA vs. AA (dominant mode) was sig-
niﬁcantly lower among cases than controls (76.1% vs. 91.8%,
p= 0.01, OR= 0.3, 95% CI (0.1–0.7)). In the meantime, the
frequency of GA vs. AA (additive mode) was signiﬁcantly
higher among cases than controls (86% vs. 66.0%,
P= 0.009, OR 0.3, 95% CI (0.1–0.7)). Otherwise, compared
to controls, cases showed statistically non-signiﬁcant fre-
quency of genotypes corresponding to IL-6-174 G > C poly-
morphism-CC + GC vs. GG, dominant mode – (92.0% vs.
94.9%, p= 0.5, OR = 0.6 (0.16–2.4)). Whereas, comparingdied cytokine genes.
product size (bp) PCR conditions
30 cycles: 94 C (30 s), 60 C
(60 s), 72 C (60 s) then 72 C (7 min)
30 cycles: 94 C (30 s), 54 C (60 s), 72 C
(60 s) then 72 C (7 min)
30 cycles: 96 C (45 s), 55 C (80 s) and 72 C
(2 min), then 72 C (3 min)
242 35 cycles: 94 C (1 min), 60 C (1 min), 70 C
(1 min), then 70 C (5 min)
Table 2 Frequency of IL-10, IL-6, TNF-a and IL-1Ra genotype polymorphism among adult Egyptian asthmatic patients compared
to controls.
Genotypes Cases n (%) Control n (%) Fisher (P) OR 95% CI
IL-10-1082 A>G
Recessive mode GG vs. AA+ GA 5 (10.1) vs. 45 (89.9) 5 (5.1) vs. 93 (94.9) 0.3 2.1 0.6–7.5
Dominant mode GG+GA vs. AA 38 (76.1) vs. 12 (24.0) 90 (91.8) vs. 8 (8.2) 0.01* 0.3 0.1–0.7
Additive mode GA vs. AA 33(66.0) vs. 12(24.0) 85(86.0) vs. 8(8.2) 0.009* 0.3 0.1–0.7
Additive mode GA vs. GG 33(66.0) vs. 5(10.1) 85(86.0)vs. 5(5.1) 0.15 0.4 0.1–1.4
IL-6-174 G > C
Recessive mode CC vs. GG+GC 3(6.0)vs. 47(94.0) 6(6.1)vs. 92(93.9) 1.000 0.978 0.23–4.09
Dominant mode CC+ GC vs. GG 46(92.0) vs.4(8.0) 93(94.9) vs. (5(5.1) 0.5 0.62 0.16–2.4
Additive mode GC vs. GG 43(86.0) vs. 4(8.0) 87(88.8) vs. 5(5.1) 0.5 0.62 0.16–2.4
Additive mode GC vs. CC 43(86.0) vs. 3(6.0) 87(88.8) vs. 6(6.1) 1.0 0.99 0.24–4.14
TNF-a-308 G > A
Recessive mode AA vs. GG+ GA 7(14.0) vs. 43(86) 11(11.2) vs.87(88.8) 0.6 1.3 0.47–3.6
Dominant mode AA+GA vs. GG 36(72.0) vs. 14(28.0) 92(93.9) vs. 6(6.1) 0.001** 0.17 0.06–0.47
Additive mode GA vs. AA 29(58.0) vs. 7(14.0) 81(82.7) vs. 11(11.2) 0.28 0.6 0.2–1.6
Additive mode GA vs. GG 29(58.0) vs. 14(28.0) 81(82.7) vs. 6(6.1) 0.0004** 0.15 0.05–0.44
IL-1RA VNTR
Dominant mode A1A1 vs. A1A2 45(90.0) vs. 5(10.0) 57(58.8) vs. 40(41.2) 0.0003** 6.31 2.30–17.31
Additive mode A1A2 vs. A1A1 5(10.0) vs. 45(90.0) 40(41.2) vs. 57(58.8) 0.0003** 0.15 0.05–0.43
* Signiﬁcant at P< 0.05.
** Signiﬁcant at P< 0.001.
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TNF-a-308 G > A polymorphism, it was noticed that the fre-
quency of AA+ GA vs. GG (dominant mode) was signiﬁ-
cantly higher among cases than controls (72.0% vs. 93.9%,
p= 0.001, OR= 0.17, 95% CI (0.06–0.47)). While, the fre-
quency of GA vs. GG (additive mode) was highly signiﬁcant
among cases than controls (58.0% vs. 82.7%, P= 0.0004,
OR 0.15, 95% CI (0.05–0.44)). Regarding to the frequency
of genotypic variants related to IL-1RA VNTR polymor-
phism, it was noticed that the frequency of A1A1 vs. A1A2
(dominant mode) was signiﬁcantly higher among cases than
controls (90.0% vs. 58.8%, p= 0.0003, OR= 6.31, 95% CI
(2.3–17.3)). The frequency of A1A2 vs. A1A1 (additive mode)
was highly signiﬁcant among cases than controls (10.0% vs.
41.2%, P= 0.0003, OR 0.15, 95% CI (0.05–0.43)) (Table 2).
Discussion
Gene-by-environmental factor seems to be a key process in the
development and expression of asthma (Choi et al., 2008). The
airway inﬂammatory component of asthma is partly controlled
by the genetic background of the patients (Holgate et al.,
1995). Whereas, several linkage and association studies have
suggested the presence of various candidate atopy and asthma
genes, it is difﬁcult to detect consistent abnormalities in these
genes that may have disease-modifying effects (Wjst et al.,
1999).
Most association studies of polymorphisms in the promoter
region of IL-10 and asthma-related phenotypes have been po-
sitive. Although these polymorphisms have been shown to
inﬂuence levels of IL-10 expression, there have been conﬂicting
ﬁndings with regard to the direction of these associations
(Movahedi et al., 2008). Our current study showed a signiﬁcant
association between IL-10-1082 AA genotypic polymorphism
(dominant mode) and asthma in adult Egyptian patients. This
result is in agreement with the ﬁnding of Trajkov et al. inMacedonian population (Trajkov et al., 2008). In addition this
present study showed a signiﬁcant association between IL-10-1082
GA genotypic polymorphism (additive mode) and asthma in
adult Egyptian patients. Also, in a previous study done on
asthmatic Egyptian children, Zedan et al. reported that
IL-10-1082GA genotypes may be contributing factors to the
susceptibility and severity of childhood asthma (Zedan et al.,
2008). IL-10-1082GA polymorphism was also conﬁrmed to
be associated with asthma in Iranian population (Movahedi
et al., 2008), North Indians (Kim et al., 2008) and in Chinese
patients (Zhang et al., 2002). On the other hand, IL-10 poly-
morphism was not found to be related to susceptibility of
asthma in adult Finnish population (Karjalainen et al., 2003).
Analysis of genetic polymorphism of IL-6-174 in asthmatic
Egyptian patients revealed a non-signiﬁcant association, how-
ever, in a previous study; researchers reported a signiﬁcant
association between IL-6-174 GG and asthma in Egyptian
children (Settin et al., 2008). This same association was found
positive in another study conducted on Iranian subjects with
asthma (Mahdaviani et al., 2009). The difference in genetic
polymorphisms associated with childhood and adult asthma
possibly points to the different pathophysiological mechanisms
underlying both entities which also coincide with the different
presentations of both types of asthma.
Results of the current study showed that TNF-a-308 GG
(dominant mode) polymorphism is signiﬁcantly associated
with chronic asthma in adult Egyptian patients. It was previ-
ously reported that TNF-a-308 GA genotypic polymorphism
may be a contributing factor to the susceptibility and severity
of asthma in Egyptian children (Zedan et al., 2008). A similar
ﬁnding was reported by Witte et al. (2002) that TNF-a-308
GG was positively associated with asthma in Californian pa-
tients. Previous association studies concluded that TNF-a-
308 GA promoter polymorphism was signiﬁcantly associated
with asthma in North Indian patients (Choi, 2005; Gupta
et al., 2005; Gao et al., 2006), Punjabi population (Kumar
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Korean children (Kim et al., 2008). Another study of G-308A
TNF-a polymorphism on children from Western Australia re-
vealed that the G allele was present at higher frequency in asth-
matics as compared to controls (Albuquerque et al., 1998). On
the contrary, other investigators failed to ﬁnd an association
between G-308A polymorphic alleles and asthma among:
Turkish population (Buckova´ et al., 2002; Aytekin et al.,
2009) and American population (El Bahlawan et al., 2003).
The polymorphism of IL-1 receptor antagonist (IL-1Ra)
gene has been previously investigated in different populations
with asthma (Gohlke et al., 2004; Pattaro et al., 2006). Analy-
sis of IL-1Ra VNTR polymorphism in adult Egyptian patients
with asthma showed the presence of high signiﬁcant frequency
of the homozygous genotype forms A1/A1 (dominant mode)
and A1A2 (additive mode). This ﬁnding is matched with a pre-
vious study conducted on Egyptian children with asthma (Set-
tin et al., 2008). The same ﬁnding was also reported in a
previous study among Turkish children with asthma (Zeyrek
et al., 2008). Analysis of allelic polymorphism of all studied
genes revealed only IL-1Ra A1 allele that showed signiﬁcant
higher frequency among chronic adult asthmatic cases com-
pared to controls among Egyptian population. Pillay et al.
(2000) studied different allelic polymorphisms of IL-Ra and
concluded that the IL-1 Ra is a marker of disease severity in
asthma, particularly in black patients.
From this study, it is concluded that cytokine gene polymor-
phisms showed a positive association with chronic asthma that
might suggest their usage as markers for asthma among Egyp-
tian families with a potential impact on prophylactic and or
therapeutic measures for asthma control. However we recom-
mend further longitudinal study with a larger sample size and
familial cases for further association and linkage analyses.References
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